US2007078188A1PendingUtilityA1

Compositions comprising and methods of using norfluoxetine

58
Individually held — no corporate assignee on recordPriority: Jul 2, 2001Filed: Apr 20, 2006Published: Apr 5, 2007
Est. expiryJul 2, 2021(expired)· nominal 20-yr term from priority
Inventors:Mark G. CurrieSteven JonesChrisantha H. SenanayakeZhi-Hiu Lu
A61K 31/56A61K 31/137A61K 45/06
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention encompasses methods of using racemic and enantiomerically pure norfluoxetine, as well as pharmaceutical compositions, pharmaceutical unit dosage forms, and kits comprising racemic and enantiomerically pure norfluoxetine. In particular, the invention encompasses a method of inhibiting or reducing the production of PGE 2 . The invention further encompasses a method of treating or preventing inflammation in a patient, as well as a method of treating or preventing a disease or disorder such as, but not limited to, autoimmune diseases, arthritis, neurologic diseases, inflammatory diseases, fibromyalgia, pain resulting from inflammation, neuropathic pain, and cancer.

Claims

exact text as granted — not AI-modified
1 - 17 . (canceled)  
   
   
       18 . A pharmaceutical composition comprising norfluoxetine, or a pharmaceutically acceptable salt, solvate, hydrate, or clathrate thereof.  
   
   
       19 - 62 . (canceled)

Join the waitlist — get patent alerts

Track US2007078188A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.